Helicobacter pylori surface and mucosal components

Helicobacter pylori surface and mucosal components represent the complex molecular interface between the Gram-negative bacterium H. pylori and the human gastric mucosa (Source: NIH, StatPearls). This target encompasses bacterial surface factors such as urease, adhesins like BabA and SabA, and lipopolysaccharides, as well as host mucosal elements like mucin glycoproteins (Source: PubMed). These components are critical for the bacterium's ability to survive the acidic environment of the stomach, adhere to epithelial cells, and induce chronic inflammation (Source: Wikipedia). Therapeutic agents like bismuth subsalicylate act by binding to these surface and mucosal components, creating a protective physical barrier and inhibiting bacterial colonization (Source: DrugBank). This interaction also leads to the inhibition of bacterial enzymes and the disruption of the bacterial cell wall, contributing to the eradication of the infection (Source: PubChem). Targeting this interface is a primary strategy in the treatment of peptic ulcers and the prevention of gastric cancer (Source: NIH). The complexity of this target reflects the multifaceted nature of H. pylori pathogenesis and the host's defensive response (Source: PubMed).

Other names

H. pylori surface antigensGastric mucosal interfaceBacterial surface and mucosal componentsH. pylori colonization factors

Bismuth compounds bind to bacterial surface proteins and host mucosal mucins, forming a protective coating that inhibits bacterial adhesion and exerts direct bactericidal effects by disrupting the cell wall and inhibiting enzymes like urease.